Glioblastoma treatment still stalls beyond Stupp, while meningioma lacks systemic salvage options; Singh highlights adaptive trials, molecular profiling, and young-patient quality-of-life risks.
Raj Singh, MD
Advertisement
Raj Singh, MD, is a radiation oncologist at the Eugene M. and Christine E. Lynn Cancer Institute, part of Baptist Health.
Articles by Raj Singh, MD
Raj Singh, MD, discusses treatment gaps, emerging therapies, and the critical role of multidisciplinary care in managing brain tumors.
Dr Raj Singh discusses radiation strategies, dose escalation, PCI debates, and multidisciplinary collaboration in small cell lung cancer management.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Advanced Renal Cell Carcinoma: Summarizing a Practical First-Line Treatment Algorithm
2
Exploring Psilocybin-Assisted Therapy for Cancer Patients' Trauma
3
FDA Approves Gedatolisib for HR+/HER2−, PIK3CA Wild-Type Advanced Breast Cancer
4
Allostatic Load: The Role of Chronic Stress in Predicting Early-Onset Cancer Risk
5